Brind.

Needham & Company provided research reports on Geron Corporation, coinciding with a filing with the SEC confirming institutional investment activity.

1 report, 1 independent Updated 00:00

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Geron Corporation Needham & Company Securities and Exchange Commission

Keep exploring

The entities involved

Geron Corporation
company
- Geron Corporation presented clinical data at the American Society of Hematology meeting.Wed 16:24
Needham & Company
American independent investment bank and asset management firm
- Needham & Company raised its price objective and issued a buy rating for Ceragon Networks, with MarketBeat reporting consensus data.09:35
- Needham & Company raised its price target and gave an 'outperform' rating for Steven Madden, Ltd., whose stock is listed on the Nasdaq exchange.09:05
Securities and Exchange Commission
government agency of the Philippines
- Financial institutions, including Citigroup and RBC, filed 13F reports and adjusted analyst ratings with the SEC.11:34
- F5, Inc. filed disclosures regarding share purchases with the Securities and Exchange Commission.03:05

Related events

S&P Global filed required reports with the SEC, concurrent with Jefferies Financial Group providing research reports and price targets on June 26, 2026.Jun 26

Coverage

Newest first; wire copies grouped

00:00dailypolitical.com